首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Occurrence and behaviour of pharmaceutical compounds in a Portuguese wastewater treatment plant: Removal efficiency through conventional treatment processes
Authors:Vanessa de Jesus Gaffney  Vitor Vale Cardoso  Eugénia Cardoso  Ana Paula Teixeira  José Martins  Maria João Benoliel  Cristina Maria Martins Almeida
Institution:1.iMed.UL (Institute for Medicines and Pharmaceutical Sciences, Portugal), Faculdade de Farmácia da Universidade de Lisboa (FFUL),Lisbon,Portugal;2.Empresa Portuguesa das águas Livres, S.A.—EPAL, Dire??o de Controlo da Qualidade da água,Lisbon,Portugal;3.Empresa Portuguesa das águas Livres, S.A.—EPAL, Dire??o de Opera??es de Saneamento, ETAR de Beirolas,Sacavém,Portugal;4.FFUL, Laboratório de Bromatologia e Qualidade da água,Lisbon,Portugal
Abstract:Wastewater treatments can eliminate or remove a substantial amount of pharmaceutical active compounds (PhACs), but there may still be significant concentrations of them in effluents discharged into surface water bodies. Beirolas wastewater treatment plant (WWTP) is located in the Lisbon area and makes its effluent discharges into Tagus estuary (Portugal). The main objective of this study is to quantify a group of 32 PhACs in the different treatments used in this WWTP. Twelve sampling campaigns of wastewater belonging to the different treatments were made in 2013–2014 in order to study their removal efficiency. The wastewaters were analysed by solid phase extraction (SPE) and ultra-performance liquid chromatography coupled with tandem mass detection (UPLC–MS/MS). The anti-diabetics were the most frequently found in wastewater influent (WWI) and wastewater effluent (WWE) (208 and 1.7 μg/L, respectively), followed by analgesics/antipyretics (135 μg/L and < LOQ, respectively), psychostimulants (113 and 0.49 μg/L, respectively), non-steroidal anti-inflammatory drugs (33 and 2.6 μg/L, respectively), antibiotics (5.2 and 1.8 μg/L, respectively), antilipidemics (1.6 and 0.24 μg/L, respectively), anticonvulsants (1.5 and 0.63 μg/L, respectively) and beta blockers (1.3 and 0.51 μg/L, respectively). A snapshot of the ability of each treatment step to remove these target PhACs is provided, and it was found that global efficiency is strongly dependent on the efficiency of secondary treatment. Seasonal occurrence and removal efficiency was also monitored, and they did not show a significant seasonal trend.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号